NorthWest Biotherapeutics Inc (NWBO)

[abc1212]

Senti, in light of Linda Liau receiving the same award this year, this is very interesting.

Could I ask you regarding the section

And five, or 25% of the group of 25 patients were long-term survivors and lived 36 months or longer.

I think if it was five out of 25 patients, then wouldn't that be only 20% and not 25%

As you point out though, if Dr Lang thought this data was "a remarkable result for a glioblastoma phase one trial." then based on this, doesn't that make DCVax-L results even more remarkable.